Swell in Off-Label Antipsychotic Prescribing ' Not Harmless ' Swell in Off-Label Antipsychotic Prescribing ' Not Harmless '

A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Psychiatry News Source Type: news